{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:55:55Z","timestamp":1776318955612,"version":"3.50.1"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of this study was to investigate the association between remnant cholesterol (RC) levels and non-alcoholic fatty liver disease (NAFLD) in patients diagnosed with type 2 diabetes mellitus (T2DM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants and methods<\/jats:title>\n                    <jats:p>This was a cross-sectional study involving 308 patients with T2DM who were hospitalized at Hebei General Hospital. The participants were categorized into a NAFLD group and a non-NAFLD (control) group, and comparative analyses were conducted between the groups. Regression analysis, subgroup analysis, and interaction tests were performed. Additionally, restricted cubic spline (RCS), predicted probability, and sensitivity analyses were used to explore and verify the association between RC levels and NAFLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Elevated RC levels were associated with NAFLD (OR = 4.23, 95% CI: 1.73\u201312.04) after adjusting for all confounding factors, regardless of whether RC was treated as a continuous or tertile variable. No significant interactions were observed for any of the subgroups, including age (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.772), gender (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.231), diabetes duration (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.757), BMI (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.221), and HbA1c (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.916). RCS analysis indicated that there was a significant association between RC levels and NAFLD (\n                      <jats:italic>P<\/jats:italic>\n                      overall = 0.006), and the relationship was linear (\n                      <jats:italic>P<\/jats:italic>\n                      nonlinear = 0.399). The mean predicted probability of NAFLD increased with increasing RC concentration, rising from 65.7% (95% CI: 53.6%\u221276.1%) at 0.2 mmol\/L to 85.8% (95% CI: 76.9%\u221291.7%) at 1.0 mmol\/L. In the sensitivity analysis, when RC was categorized into tertiles, the association between RC levels and NAFLD remained significant across all models (Model 3: Tertile 3 vs. Tertile 1, OR = 2.05, 95% CI: 1.06\u20134.03,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.035). Furthermore, a significant linear trend was observed (\n                      <jats:italic>P<\/jats:italic>\n                      trend = 0.035), confirming the robustness of the primary findings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In patients with T2DM, RC levels are independently associated with NAFLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1782646","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:25:55Z","timestamp":1776317155000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Elevated remnant cholesterol is linked to non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus"],"prefix":"10.3389","volume":"13","author":[{"given":"Hang","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Hebei General Hospital, Shijiazhuang","place":["Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hebei General Hospital, Shijiazhuang","place":["Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunjia","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hebei General Hospital, Shijiazhuang","place":["Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhui","family":"Jiang","sequence":"additional","affiliation":[{"name":"Geriatrics, Harbin 242 Hospital, Harbin","place":["Heilongjiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuijuan","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hebei General Hospital, Shijiazhuang","place":["Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luping","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hebei General Hospital, Shijiazhuang","place":["Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuchun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hebei General Hospital, Shijiazhuang","place":["Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin PR."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"HEPATOLOGY."},{"key":"B3","doi-asserted-by":"publisher","first-page":"955","DOI":"10.14218\/JCTH.2024.00311","article-title":"Guideline for the prevention and treatment of metabolic dysfunction-associated fatty liver disease (version 2024)","volume":"12","author":"Fan","year":"2024","journal-title":"J CLIN TRANSL HEPATO."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/hep.32771","article-title":"AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma","volume":"77","author":"Bowlus","year":"2023","journal-title":"Hepatology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.21037\/hbsn-22-421","article-title":"An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease","volume":"12","author":"Sun","year":"2023","journal-title":"Hepatobil Surg Nutr."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscl Throm Vas."},{"key":"B8","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1093\/eurheartj\/ehs431","article-title":"Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction","author":"J\u00f8rgensen","year":"2013","journal-title":"Eur Heart J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1098078","DOI":"10.3389\/fendo.2023.1098078","article-title":"Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease","volume":"14","author":"Cheng","year":"2023","journal-title":"Front Endocrinol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3390\/jcm7110378","article-title":"Remnant lipoprotein cholesterol and cardiovascular and cerebrovascular events in patients with non-alcoholic fatty liver disease","volume":"7","author":"Pastori","year":"2018","journal-title":"J Clin Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"100150","DOI":"10.1016\/j.jhepr.2020.100150","article-title":"Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents","volume":"2","author":"Chin","year":"2020","journal-title":"JHEP Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1016\/j.jacc.2020.10.029","article-title":"Remnant cholesterol and atherosclerotic cardiovascular disease risk","volume":"76","author":"Burnett","year":"2020","journal-title":"J AM Coll Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12933-022-01667-6","article-title":"Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study","volume":"21","author":"Huh","year":"2022","journal-title":"Cardiovasc Diabetol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1210\/er.2018-00184","article-title":"The forgotten lipids: triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk","volume":"40","author":"Sandesara","year":"2019","journal-title":"Endocrine Rev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e13498","DOI":"10.1111\/1753-0407.13498","article-title":"Association of remnant cholesterol and newly diagnosed early-onset type 2 diabetes mellitus in Chinese population: a retrospective cross-sectional study","volume":"16","author":"Dong","year":"2024","journal-title":"J Diabetes."},{"key":"B16","doi-asserted-by":"publisher","first-page":"110733","DOI":"10.1016\/j.diabres.2023.110733","article-title":"Remnant cholesterol has a non-linear association with non-alcoholic fatty liver disease","volume":"201","author":"Chen","year":"2023","journal-title":"Diabetes Res Clin Pract."},{"key":"B17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cca.2014.10.029","article-title":"The role of circulating lipoprotein lipase and adiponectin on the particle size of remnant lipoproteins in patients with diabetes mellitus and metabolic syndrome","volume":"440","author":"Shirakawa","year":"2015","journal-title":"Clinica Chim Acta."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.cca.2010.07.004","article-title":"Delayed postprandial metabolism of triglyceride-rich lipoproteins in obese young men compared to lean young men","volume":"411","author":"Nabeno-Kaeriyama","year":"2010","journal-title":"Clin Chim Acta."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1161\/CIRCULATIONAHA.113.003008","article-title":"Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation","volume":"128","author":"Varbo","year":"2013","journal-title":"Circulation."},{"key":"B20","doi-asserted-by":"publisher","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol Metab."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1265\/ehpm.23-00289","article-title":"Not only baseline but cumulative exposure of remnant cholesterol predicts the development of nonalcoholic fatty liver disease: a cohort study","volume":"29","author":"Liu","year":"2024","journal-title":"Environ Health Prev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/hep.26672","article-title":"Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes","volume":"59","author":"Birkenfeld","year":"2014","journal-title":"Hepatology."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1782646\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:25:56Z","timestamp":1776317156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1782646\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":22,"alternative-id":["10.3389\/fnut.2026.1782646"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1782646","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"article-number":"1782646"}}